Skip to content

Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery

Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Critically Ill Patients After Cardiothoracic Surgery. An Ultrasound-Based Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02391103
Acronym
Catastim 2
Enrollment
54
Registered
2015-03-18
Start date
2011-05-31
Completion date
2015-03-31
Last updated
2015-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Electrical Stimulation, Intensive Care Unit Acquired Weakness, Muscle Wasting, Muscle Loss

Brief summary

The purposes of this study are 1) to determine whether neuromuscular electrical stimulation (NMES) is effective in preventing loss of muscle mass and strength and 2) to observe the time variation of MLT and strength from preoperative day to hospital discharge.

Detailed description

In the amendment of June 2011, a twofold study setting was defined in order to recruit patients not only before, but also after cardiothoracic surgery. In sample A, patients were recruited before surgery. In sample B, patients were recruited after surgery. On postoperative day 1, randomization was performed for sample A and B separately. To ensure balance of the NMES and control groups with respect to disease severity, randomization was stratified by the SAPS II score on the first postoperative day. In the intervention group, the anterior muscles of both thighs were electrically stimulated from the first postoperative day until ICU discharge for a maximum of 14 days. In the control group, the electrodes were applied, but no electricity was delivered.The primary outcomes muscle layer thickness (MLT) and muscle strength were assessed from the first postoperative day to ICU discharge and at hospital discharge. All patients in sample A had an additional assessment of MLT and strength before surgery. All data are analyzed according to the intention-to-treat principle with no imputation for any missing data. Linear mixed models are used to account for the repeated measurements per patient and to determine any fixed effects on MLT and MRC score.

Interventions

DEVICECompex 3 Professional (CefarCompex Medical AB) stimulator

NMES

no electricity applied

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients before/after cardiothoracic surgery * ICU stay \> 48 hours

Exclusion criteria

* body mass index \> 40 kg/m2 * severe leg swelling * implanted ventricular assist device (RVAD, LVAD, BiVAD) * implanted intra-aortic balloon pump (IABP) * neuromuscular diseases * skin lesions in stimulation area * leg excluded if implant (hip or knee replacement) in stimulation area

Design outcomes

Primary

MeasureTime frameDescription
Muscle layer thickness (MLT)on preoperative day, from postoperative day 1 onwards every other ICU day for the duration of the ICU stay (expected average of ICU stay: 7 days) and at day of hospital discharge (expected average of hospital stay: 20 days)Muscle layer thickness of the anterior muscles of the thigh using two-dimensional B-mode ultrasound
Muscle strengthon preoperative day, from postoperative day 1 onwards every day for the duration of the ICU stay (expected average of ICU stay: 7 days), at day of hospital discharge (expected average of hospital stay: 20 days)Muscle strength using Medical Research Council (MRC) score and hand dynamometry

Secondary

MeasureTime frameDescription
JAGS scoreon preoperative day, on day of ICU discharge (expected average of ICU stay: 7 days), on day of hospital discharge (expected average of hospital stay: 20 days)JAGS score
Timed Up and Go teston preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)Timed Get Up and Go test
FIM scoreon preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)Functional Independance Measure (FIM) score
SF-12 scoreon preoperative day, on day of hospital discharge (expected average of hospital stay: 20 days)12-item Short Form Health Survey (SF-12)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026